The diagnostic value of five serum tumor markers for patients with cholangiocarcinoma - ScienceDirect
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - Clinical Gastroenterology and Hepatology
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma - Jaklitsch - Translational Gastroenterology and Hepatology
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
CA 19-9: handle with care
Diagnostic Role of Serum CA 19-9 for Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis - ScienceDirect
![PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a96fc01f495907ea18214fdc7db7ffd9b210d72c/2-TableI-1.png "PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar")
PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
Tumor marker analysis in the cases with and without cholangiocarcinoma | Download Table
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging | SpringerLink
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
Biomarkers of intrahepatic cholangiocarcinoma: diagnosis and response to therapy
PDF) CA 19?9 and CE A are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis | Einar Björnsson - Academia.edu
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
